This wiki has undergone a migration to Confluence found Here
Difference between revisions of "HL7 Stability Standard Implementation Guide Teleconference Minutes 2011-01-24"
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
*The attached e-mail from Art Griesser (http://gforge.hl7.org/gf/download/docmanfileversion/6111/7978/E-Mail.doc) with question about SPL schematron rules and/or the schematron implementation used for SPL along with a pdf file (http://gforge.hl7.org/gf/download/docmanfileversion/6112/7979/schematron_implementations.pdf) about schematron implementations. I did forward the e-mail to the FDA SPL people and to the SPL schematron developer. If you use SPL or are familiar with schematron please take a look at the e-mail and respond if you know the answer to any of the questions. | *The attached e-mail from Art Griesser (http://gforge.hl7.org/gf/download/docmanfileversion/6111/7978/E-Mail.doc) with question about SPL schematron rules and/or the schematron implementation used for SPL along with a pdf file (http://gforge.hl7.org/gf/download/docmanfileversion/6112/7979/schematron_implementations.pdf) about schematron implementations. I did forward the e-mail to the FDA SPL people and to the SPL schematron developer. If you use SPL or are familiar with schematron please take a look at the e-mail and respond if you know the answer to any of the questions. | ||
− | * | + | *The attached file (http://gforge.hl7.org/gf/download/docmanfileversion/6113/7980/HL7DrugStabilityReportingValidationProcedures1-24-11.doc) is the validation document (HL7 Drug Stability Reporting Validation Procedures (1-24-11).doc) which has all the edited and revised information from the elements (1-24-11).doc inserted in Section 1.3 Document information. Once we are satisfied with the information in this section we will look at the total document. |
'''Agenda for January 31, 2011 Teleconference:''' | '''Agenda for January 31, 2011 Teleconference:''' |
Latest revision as of 14:35, 25 January 2011
HL7 Stability Standard Pilot/Implementation Guide Teleconference Minutes
January 24, 2011
Attendees:
Norman Gregory (CVM), David Longstaff (CVM), Tim Lee (CBER), Catherine Hosage-Norman (Sunovion), Mike Yang (ScienTek Software), Edward Pec (Abbott Laboratories), Jennifer Rice (Alpharma), and Sandra Spiewak (Reed Technology and Information Services Inc.)
- The attached e-mail from Art Griesser (http://gforge.hl7.org/gf/download/docmanfileversion/6111/7978/E-Mail.doc) with question about SPL schematron rules and/or the schematron implementation used for SPL along with a pdf file (http://gforge.hl7.org/gf/download/docmanfileversion/6112/7979/schematron_implementations.pdf) about schematron implementations. I did forward the e-mail to the FDA SPL people and to the SPL schematron developer. If you use SPL or are familiar with schematron please take a look at the e-mail and respond if you know the answer to any of the questions.
- The attached file (http://gforge.hl7.org/gf/download/docmanfileversion/6113/7980/HL7DrugStabilityReportingValidationProcedures1-24-11.doc) is the validation document (HL7 Drug Stability Reporting Validation Procedures (1-24-11).doc) which has all the edited and revised information from the elements (1-24-11).doc inserted in Section 1.3 Document information. Once we are satisfied with the information in this section we will look at the total document.
Agenda for January 31, 2011 Teleconference:
- We will continue to use Adobe connect (to join the meeting: https://collaboration.fda.gov/hl7/).
- Schematron progress update
- eStability Validation Procedures document and element document.